Tag: Neuromodulation
-
Directional DBS system targets GPi to relieve Parkinson’s symptoms
Abbott received FDA approval for an expanded indication for its Deep Brain Stimulation system, to include targeting of internal globus pallidus. The GPi plays an integral role in motor function. When targeted with DBS, Parkonson’s symptoms not adequately controlled by medication can improve. The directed stimulation system is now approved for all major targets used…